Professor Patrick Aebischer is a Swiss citizen and he was born on November 22, 1954. Patrick Aebischer was trained as an MD (1980) and a Neuroscientist (1983) at the Universities of Geneva and Fribourg in Switzerland. From 1984 to 1992, he worked at Brown University in Providence (Rhode Island, U.S.) as an Assistant and then Associate Professor of Medical Sciences.In 1991, he became the chairman of the Section of Artificial Organs, Biomaterials and Cellular Technology of the Division of Biology and Medicine of Brown University. In the fall of 1992, he returned to Switzerland as a Professor and Director of the Surgical Research Division and Gene Therapy Center at the Centre Hospitalier Universitaire Vaudois (CHUV) in Lausanne.In 1999, Patrick Aebischer was appointed President of the Ecole Polytechnique Federale de Lausanne (EPFL) by the Swiss Federal Council. He took office on 17 March, 2000. President Aebischer is also member of the ETH Board since 2004.He is a member of numerous professional societies, both in Europe and America. He is a fellow of the American Institute for Medical and Biological Engineering and of the Swiss Academy of Medicine.Patrick Aebischer is also the founder of three biotechnology companies. His current research focuses on the development of cell and gene transfer approaches for the treatment of neurodegenerative diseases.
AEBISCHER PATRICK
Classe di scienze fisiche, matematiche e naturali
Area disciplinare: SCIENZE BIOLOGICHE
Data elezione: s.s. 23 aprile 2013
Professeur ordinaire in Neurosciences nell'Ècole Polytechnique Fédérale di Losanna
Patrick Aebischer è un Professore ordinario in Neuroscienze presso l’École Polytechnique Fédérale di Losanna (EPFL). È stato nominato membro dell’Istituto Veneto di Scienze, Lettere ed Arti il 23 aprile 2013. Cittadino svizzero nato nel 1954, si è formato come medico e neuroscienziato prima di lavorare alla Brown University negli Stati Uniti. Tornato in Svizzera, è stato Presidente dell’EPFL dal 17 marzo 2000. È anche fondatore di tre aziende di biotecnologia e la sua ricerca si concentra sulle malattie neurodegenerative.